Daily Harvest issued a new statement weeks after it voluntarily recalled its French Lentil and Leek Crumbles. The company that specializes in Chef-crafted meal deliveries announced that it has finally found what may be causing the illness of some customers.
As per CNN Business, Daily Harvest has been working with the US Food and Drug Administration (USFDA) in finding what exactly is making people sick after consuming its crumbles product. The investigations have been going on for a few weeks now and the company’s last update stated that it failed to find the problem.
Then again, Daily Harvest’s chief founder and chief executive officer, Rachel Drori, assured their customers that they will not stop testing until they find the source of the sickness. A week after this message was posted, the CEO released a new notice and revealed they have finally found the possible cause of the illnesses such as gastrointestinal illness and abnormal liver function.
“At this time, we have identified tara flour as the cause of the issue. Our extensive investigation has involved many experts analyzing data from all sources,” Drori, said in a statement. “We have only used this ingredient in French Lentil + Leek Crumbles and we are no longer sourcing from this producer who does not provide any ingredients for our 140+ other items.”
She went on to say, “This was the first and only time we have used tara flour, which has been available and used in the North American market as a plant-based source of protein prior to our use. Our investigation team will continue working with the FDA, the tara flour producer and others to help determine what specifically made people sick.”
While Daily Harvest identified the tara flour as the culprit, it has never mentioned the producer of the product. The company was sued after some customers complained they developed mysterious illnesses after consuming the French Lentil & Lee Crumbles.
Most of the complainants are online influencers who have tested the product through their online channels as a way of promoting the item to the public. However, some of them became seriously ill and even required hospitalizations, so they filed a lawsuit.


SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Japan's Business Confidence Rises Despite Iran War Uncertainty, BOJ Rate Hike Expected
U.S. Job Market Braces for Slow Recovery Amid Middle East Tensions and Economic Uncertainty
Gold Prices Surge as U.S.-Iran Ceasefire Talks Spark Market Optimism
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
RBI Clamps Down on Rupee NDF Activity, Banks Face Steeper Losses
Bank of Japan Eyes Further Rate Hikes Amid Middle East Tensions and Inflation Pressures
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
South Korea Manufacturing PMI Hits 4-Year High in March 2025 Driven by Semiconductor Demand
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Gold Prices Rebound But Head for Worst Month Since 2008 Amid Iran War Uncertainty
Trump's Iran War Speech Sparks Market Anxiety Over Extended Conflict
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage 



